The interaction between PD-1 and PD-L1 negatively regulates the activation and function of T cells, eliminating T cells and leading to immunosuppression in cancer patients (Keir et al., 2008; Bagchi et al., 2021). This evidence concerns the gene PDCD1 and cancer.